Will highly sensitive thyroglobulin assays change the management of thyroid cancer?

Clinical Endocrinology

Volumn 67, Issue 3, 2007, Pages 321-323

  Mazzaferri, Ernest L ^a,b,c  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN;

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID CANCER;

CARCINOMA, PAPILLARY; CHEMISTRY, CLINICAL; FEMALE; HUMANS; MALE; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548046458     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02899.x     Document Type: Note

References (16)

1. Davies, L. Welch, H.G. (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association, 295, 2164 2167.
2. Leenhardt, L., Bernier, M.O., Boin-Pineau, M.H., Conte, D.B., Marechaud, R., Niccoli-Sire, P., Nocaudie, M., Orgiazzi, J., Schlumberger, M., Wemeau, J.L., Cherie-Challine, L. De Vathaire, F. (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. European Journal of Endocrinology, 150, 133 139.
3. Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J.W. Wiersinga, W. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787 803.
4. Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Mazzaferri, E.L., McIver, B., Sherman, S.I. Tuttle, R.M. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109 141.
5. Mazzaferri, E.L. (2006) Managing small thyroid cancers. Journal of the American Medical Association, 295, 2179 2182.
6. Pacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L. Pinchera, A. (2003) Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 3668 3673.
7. Spencer, C.A., Bergoglio, L.M., Kazarosyan, M., Fatemi, S. LoPresti, J.S. (2005) Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism, 90, 5566 5575.
8. Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., Haugen, B.R., Sherman, S.I., Cooper, D.S., Braunstein, G.D., Lee, S., Davies, T.F., Arafah, B.M., Ladenson, P.W. Pinchera, A. (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 1433 1441.
9. Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., Cooper, D.S., Graham, K.E., Braverman, L.E., Skarulis, M.C., Davies, T.F., DeGroot, L.J., Mazzaferri, E.L., Daniels, G.H., Ross, D.S., Luster, M., Samuels, M.H., Becker, D.V., Maxon, H.R., III, Cavalieri, R.R., Spencer, C.A., McEllin, K., Weintraub, B.D. Ridgway, E.C. (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism, 84, 3877 3885.
10. Baudin, E., Cao, C.D., Cailleux, A.F., Leboulleux, S., Travagli, J.P. Schlumberger, M. (2003) Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism, 88, 1107 1111.
11. Kloos, R.T. Mazzaferri, E.L. (2005) A single recombinant human thyrotrophin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. Journal of Clinical Endocrinology and Metabolism, 90, 5047 5057.
12. Jonklaas, J., Sarlis, N.J., Litofsky, D., Ain, K.B., Bigos, S.T., Brierley, J.D., Cooper, D.S., Haugen, B.R., Ladenson, P.W., Magner, J., Robbins, J., Ross, D.S., Skarulis, M., Maxon, H.R. Sherman, S.I. (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid, 16, 1229 1242.
13. Smallridge, R.C., Meek, S.E., Morgan, M.A., Gates, G.S., Fox, T.P., Grebe, S. Fatourechi, V. (2007) Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH stimulated thyroglobulin in follow-up of thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism, 92, 82 87.
14. Bal, C.S., Kumar, A., Chandra, P., Dwivedi, S.N. Mukhopadhyaya, S. (2004) Is chest X-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid, 14, 217 225.
15. Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J.P., Caillou, B., Richard, M., Lumbroso, J.D., De Vathaire, F. Schlumberger, M. (2006) Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. Journal of Clinical Endocrinology and Metabolism, 91, 2892 2899.
16. Podnos, Y.D., Smith, D., Wagman, L.D. Ellenhorn, J.D. (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. American Surgery, 71, 731 734.